Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus

Albert J. Eid, Robert A. Brown, Carlos V. Paya, Raymund R Razonable

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

BACKGROUND. Experimental models suggest that immune cells recognize hepatitis C virus (HCV) through toll-like receptor (TLR)-2 and TLR4. We assessed the association between the single nucleotide polymorphism in genes that encode for these receptors and the outcome of liver transplantation for chronic HCV. METHODS. A historical cohort of 92 liver transplant patients with chronic HCV were screened for TLR2 Arg753Gln and TLR4 Asp299Gly and Thr399Ile polymorphisms. The results were correlated with the predefined composite primary outcome of cirrhosis, retransplantation, and death. Statistical analysis was performed using Kaplan-Meier estimation and Cox proportional hazard model. RESULTS. The mean patient age was 49±9 years. Sixty percent were male and 84% were white. Twelve (13%) patients had TLR2 Arg753Gln and 32 (35%) had TLR4 Asp299Gly and/or Thr399Ile polymorphism. During the mean follow-up period of 32 months after liver transplantation, the composite primary outcome occurred in 19 (24%) of 80 patients without TLR2 polymorphism, one (14%) of seven patients with heterozygous TLR2 polymorphism, and in all five (100%) patients with homozygous TLR2 polymorphism (P=0.0007). Time-to-event analysis showed a significant association between homozygous TLR2 polymorphism and the primary outcome (P<0.0001). After adjusting for donor age and azathioprine use, homozygous TLR2 mutation (RR 5.20 [1.65-13.9]; P=0.007) remained associated with the primary outcome. TLR4 polymorphisms were not associated with primary outcome. CONCLUSION. Homozygous TLR2 Arg753Gln polymorphism is associated with allograft failure and mortality after liver transplantation for chronic HCV. The potential clinical relevance of this observation should encourage studies to assess its biologic mechanism.

Original languageEnglish (US)
Pages (from-to)511-516
Number of pages6
JournalTransplantation
Volume84
Issue number4
DOIs
StatePublished - Aug 2007

Fingerprint

Toll-Like Receptors
Chronic Hepatitis C
Hepacivirus
Liver Transplantation
Toll-Like Receptor 2
Azathioprine
Proportional Hazards Models
Single Nucleotide Polymorphism
Allografts
Fibrosis
Theoretical Models
Tissue Donors
Transplants
Mutation
Mortality
Liver
Genes

Keywords

  • Cirrhosis
  • Polymorphism
  • Retransplantation

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. / Eid, Albert J.; Brown, Robert A.; Paya, Carlos V.; Razonable, Raymund R.

In: Transplantation, Vol. 84, No. 4, 08.2007, p. 511-516.

Research output: Contribution to journalArticle

@article{ebb1066a05154f7b8cede0215cfff998,
title = "Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus",
abstract = "BACKGROUND. Experimental models suggest that immune cells recognize hepatitis C virus (HCV) through toll-like receptor (TLR)-2 and TLR4. We assessed the association between the single nucleotide polymorphism in genes that encode for these receptors and the outcome of liver transplantation for chronic HCV. METHODS. A historical cohort of 92 liver transplant patients with chronic HCV were screened for TLR2 Arg753Gln and TLR4 Asp299Gly and Thr399Ile polymorphisms. The results were correlated with the predefined composite primary outcome of cirrhosis, retransplantation, and death. Statistical analysis was performed using Kaplan-Meier estimation and Cox proportional hazard model. RESULTS. The mean patient age was 49±9 years. Sixty percent were male and 84{\%} were white. Twelve (13{\%}) patients had TLR2 Arg753Gln and 32 (35{\%}) had TLR4 Asp299Gly and/or Thr399Ile polymorphism. During the mean follow-up period of 32 months after liver transplantation, the composite primary outcome occurred in 19 (24{\%}) of 80 patients without TLR2 polymorphism, one (14{\%}) of seven patients with heterozygous TLR2 polymorphism, and in all five (100{\%}) patients with homozygous TLR2 polymorphism (P=0.0007). Time-to-event analysis showed a significant association between homozygous TLR2 polymorphism and the primary outcome (P<0.0001). After adjusting for donor age and azathioprine use, homozygous TLR2 mutation (RR 5.20 [1.65-13.9]; P=0.007) remained associated with the primary outcome. TLR4 polymorphisms were not associated with primary outcome. CONCLUSION. Homozygous TLR2 Arg753Gln polymorphism is associated with allograft failure and mortality after liver transplantation for chronic HCV. The potential clinical relevance of this observation should encourage studies to assess its biologic mechanism.",
keywords = "Cirrhosis, Polymorphism, Retransplantation",
author = "Eid, {Albert J.} and Brown, {Robert A.} and Paya, {Carlos V.} and Razonable, {Raymund R}",
year = "2007",
month = "8",
doi = "10.1097/01.tp.0000276960.35313.bf",
language = "English (US)",
volume = "84",
pages = "511--516",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus

AU - Eid, Albert J.

AU - Brown, Robert A.

AU - Paya, Carlos V.

AU - Razonable, Raymund R

PY - 2007/8

Y1 - 2007/8

N2 - BACKGROUND. Experimental models suggest that immune cells recognize hepatitis C virus (HCV) through toll-like receptor (TLR)-2 and TLR4. We assessed the association between the single nucleotide polymorphism in genes that encode for these receptors and the outcome of liver transplantation for chronic HCV. METHODS. A historical cohort of 92 liver transplant patients with chronic HCV were screened for TLR2 Arg753Gln and TLR4 Asp299Gly and Thr399Ile polymorphisms. The results were correlated with the predefined composite primary outcome of cirrhosis, retransplantation, and death. Statistical analysis was performed using Kaplan-Meier estimation and Cox proportional hazard model. RESULTS. The mean patient age was 49±9 years. Sixty percent were male and 84% were white. Twelve (13%) patients had TLR2 Arg753Gln and 32 (35%) had TLR4 Asp299Gly and/or Thr399Ile polymorphism. During the mean follow-up period of 32 months after liver transplantation, the composite primary outcome occurred in 19 (24%) of 80 patients without TLR2 polymorphism, one (14%) of seven patients with heterozygous TLR2 polymorphism, and in all five (100%) patients with homozygous TLR2 polymorphism (P=0.0007). Time-to-event analysis showed a significant association between homozygous TLR2 polymorphism and the primary outcome (P<0.0001). After adjusting for donor age and azathioprine use, homozygous TLR2 mutation (RR 5.20 [1.65-13.9]; P=0.007) remained associated with the primary outcome. TLR4 polymorphisms were not associated with primary outcome. CONCLUSION. Homozygous TLR2 Arg753Gln polymorphism is associated with allograft failure and mortality after liver transplantation for chronic HCV. The potential clinical relevance of this observation should encourage studies to assess its biologic mechanism.

AB - BACKGROUND. Experimental models suggest that immune cells recognize hepatitis C virus (HCV) through toll-like receptor (TLR)-2 and TLR4. We assessed the association between the single nucleotide polymorphism in genes that encode for these receptors and the outcome of liver transplantation for chronic HCV. METHODS. A historical cohort of 92 liver transplant patients with chronic HCV were screened for TLR2 Arg753Gln and TLR4 Asp299Gly and Thr399Ile polymorphisms. The results were correlated with the predefined composite primary outcome of cirrhosis, retransplantation, and death. Statistical analysis was performed using Kaplan-Meier estimation and Cox proportional hazard model. RESULTS. The mean patient age was 49±9 years. Sixty percent were male and 84% were white. Twelve (13%) patients had TLR2 Arg753Gln and 32 (35%) had TLR4 Asp299Gly and/or Thr399Ile polymorphism. During the mean follow-up period of 32 months after liver transplantation, the composite primary outcome occurred in 19 (24%) of 80 patients without TLR2 polymorphism, one (14%) of seven patients with heterozygous TLR2 polymorphism, and in all five (100%) patients with homozygous TLR2 polymorphism (P=0.0007). Time-to-event analysis showed a significant association between homozygous TLR2 polymorphism and the primary outcome (P<0.0001). After adjusting for donor age and azathioprine use, homozygous TLR2 mutation (RR 5.20 [1.65-13.9]; P=0.007) remained associated with the primary outcome. TLR4 polymorphisms were not associated with primary outcome. CONCLUSION. Homozygous TLR2 Arg753Gln polymorphism is associated with allograft failure and mortality after liver transplantation for chronic HCV. The potential clinical relevance of this observation should encourage studies to assess its biologic mechanism.

KW - Cirrhosis

KW - Polymorphism

KW - Retransplantation

UR - http://www.scopus.com/inward/record.url?scp=34548189060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548189060&partnerID=8YFLogxK

U2 - 10.1097/01.tp.0000276960.35313.bf

DO - 10.1097/01.tp.0000276960.35313.bf

M3 - Article

C2 - 17713436

AN - SCOPUS:34548189060

VL - 84

SP - 511

EP - 516

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 4

ER -